CoChat

The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy

Open access
Wu, Long, Feng, Qing, Ai, Mei-Lin, Deng, Song-yun, Liu, Zhi-Yong, Huang, Li, Ai, Yu-Hang, Zhang, Lina · 2020 · Scientific Reports
Cited by 56

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

We investigated the role of dynamic changes of serum levels S100B protein in brain injury and poor outcome of sepsis. This is a prospective cohort study designed to include 104 adult patients with sepsis who are admitted to ICU from Jan 2015 to Aug 2016. Sepsis was defined as sepsis 3.0. Patients with a GCS score of <15, or at least one positive CAM-ICU score were thought to have brain dysfunction. 59 patients were diagnosed with SAE and the rest 45 patients were diagnosed with non-SAE. Serum S100B was measured on day 1 and 3 after ICU admission. Primary outcomes included brain dysfunction and 28-day/180-day mortality. The SAE group showed a significantly higher APACHE II score, SOFA scores, length of ICU stay, 28-day and 180-day mortality, serum S100B levels on day 1 and day 3. S100B levels on day 1 of 0.226 μg/L were diagnostic for SAE with 80.0% specificity and 66.1% sensitivity, and the area under (AUC) the curve was 0.728, S100B levels on day 3 of 0.144 μg/L were diagnostic for SAE with 84.44% specificity and 69.49% sensitivity, and the AUC was 0.819. In addition, the AUC for S100B on day 3 for predicting 180-day mortality was larger than for S100B on day 1 (0.731 vs. 0.611). Multiple logistic regression analysis showed that S100B3 (p = 0.001) but not S100B1 (p = 0.927) were independently correlated with SAE. Kaplan-Meier survival analysis showed that patients with S100B levels higher than 0.144 μg/L had a lower probability of survival at day 180. There were more patients with encephalopathy and a higher 28-day or 180-day mortality in the ΔS100B + group than in the ΔS100B- group. Multiple logistic regression analysis showed that SAE and IL-6 on day 3 were independently correlated with S100B dynamic increase. These findings suggest that elevated serum S100B levels on day 3 and the dynamic changes of serum S100B levels from day three to one were more associated with brain dysfunction and mortality than that on day 1 in patients with sepsis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-64200-3

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 41

  1. Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801–810 (2016). · DOI · Paper page
  2. Zhang, L. N. et al. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011. Chin Med J (Engl) 125, 828–831 (2012).
  3. Schuler, A. et al. The Impact of Acute Organ Dysfunction on Long-Term Survival in Sepsis. Crit Care Med 46, 843–849 (2018). · DOI · Paper page
  4. Eidelman, L. A., Putterman, D., Putterman, C. & Sprung, C. L. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275, 470–473 (1996).
  5. Sharshar, T., Bozza, F. & Chrétien, F. Neuropathological processes in sepsis. Lancet Neurol 13, 534–536 (2014). · DOI
  6. Mazeraud, A. et al. Neuroanatomy and Physiology of Brain Dysfunction in Sepsis. Clin Chest Med 37, 333–345 (2016). · DOI
  7. Sweis, R., Ortiz, J. & Biller, J. Neurology of Sepsis. Curr Neurol Neurosci Rep 16, 21 (2016). · DOI
  8. Hughes, C. G. et al. Endothelial Activation and Blood-Brain Barrier Injury as Risk Factors for Delirium in Critically Ill Patients. Crit Care Med 44, e809–817 (2016). · DOI
  9. Davies, D. C. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200, 639–646 (2002). · DOI · Paper page
  10. Sharshar, T., Polito, A., Checinski, A. & Stevens, R. D. Septic-associated encephalopathy–everything starts at a microlevel. Crit Care 14, 199 (2010). · DOI · Paper page
  11. Jensen, R., Marshak, D. R., Anderson, C., Lukas, T. J. & Watterson, D. M. Characterization of human brain S100 protein fraction: amino acid sequence of S100 beta. J Neurochem 45, 700–705 (1985). · DOI
  12. Bloomfield, S. M., McKinney, J., Smith, L. & Brisman, J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 6, 121–138 (2007). · DOI · Paper page
  13. Thelin, E. P., Nelson, D. W. & Bellander, B. M. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir (Wien) 159, 209–225 (2017). · DOI · Paper page
  14. Monbailliu, T., Goossens, J. & Hachimi-Idrissi, S. Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review. Biomark Med 11, 503–512 (2017). · DOI
  15. Derwall, M., Stoppe, C., Brücken, D., Rossaint, R. & Fries, M. Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study. Crit Care 13, R58 (2009). · doi:10.1186/cc7785
  16. Al Tmimi, L. et al. Serum protein S100 as marker of postoperative delirium after off-pump coronary artery bypass surgery: secondary analysis of two prospective randomized controlled trials. Clin Chem Lab Med 54, 1671–1680 (2016). · DOI
  17. Nguyen, D. N. et al. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 34, 1967–1974 (2006). · DOI · Paper page
  18. Hamed, S. A., Hamed, E. A. & Abdella, M. M. Septic encephalopathy: relationship to serum and cerebrospinal fluid levels of adhesion molecules, lipid peroxides and S-100B protein. Neuropediatrics 40, 66–72 (2009). · DOI · Paper page
  19. Nguyen, D. N. et al. Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO). Neurocrit Care 20, 367–374 (2014). · doi:10.1007/s12028-013-9874-6
  20. Weigand, M. A. et al. Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology 92, 905–907 (2000). · doi:10.1097/00000542-200003000-00057
  21. Anderson, B. J. et al. Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis. J Crit Care 36, 18–23 (2016). · DOI
  22. Piazza, O., Russo, E., Cotena, S., Esposito, G. & Tufano, R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth 99, 518–521 (2007). · DOI
  23. Yao, B., Zhang, L. N., Ai, Y. H., Liu, Z. Y. & Huang, L. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res 39, 1263–1269 (2014). · DOI
  24. Panni, J. K. & Panni, M. K. Changes in S100B levels rather than absolute values may be a better marker of severity of septic encephalopathy. Br J Anaesth 100, 419; author reply 419-420 (2008). · doi:10.1093/bja/aen009
  25. Nguyen, D. N. et al. Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock. Biomed Res Int 2014, 712742 (2014).
  26. Ehler, J. et al. Diagnostic value of NT-proCNP compared to NSE and S100B in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy. Neurosci Lett 692, 167–173 (2019). · DOI · Paper page
  27. Zenaide, P. V. & Gusmao-Flores, D. Biomarkers in septic encephalopathy: a systematic review of clinical studies. Rev Bras Ter Intensiva 25, 56–62 (2013). · DOI
  28. Pfister, D. et al. Cerebral perfusion in sepsis-associated delirium. Crit Care 12, R63 (2008). · DOI · Paper page
  29. Pfister, D. et al. Intracranial pressure in patients with sepsis. Acta Neurochir Suppl 102, 71–75 (2008). · doi:10.1007/978-3-211-85578-2_14
  30. Hsu, A. A. et al. Neurological injury markers in children with septic shock. Pediatr Crit Care Med 9, 245–251 (2008). · DOI
  31. Jorge-Ripper, C. et al. Prognostic value of acute delirium recovery in older adults. Geriatr Gerontol Int 17, 1161–1167 (2017). · DOI
  32. Ercole, A., Thelin, E. P., Holst, A., Bellander, B. M. & Nelson, D. W. Kinetic modelling of serum S100b after traumatic brain injury. BMC Neurol 16, 93 (2016). · DOI
  33. Thelin, E. P., Nelson, D. W. & Bellander, B. M. Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury. Neurocrit Care 20, 217–229 (2014). · DOI
  34. Lipcsey, M. et al. The brain is a source of S100B increase during endotoxemia in the pig. Anesth Analg 110, 174–180 (2010). · doi:10.1213/ane.0b013e3181c0724a
  35. Zhang, L. N. et al. Diagnostic and Predictive Levels of Calcium-binding Protein A8 and Tumor Necrosis Factor Receptor-associated Factor 6 in Sepsis-associated Encephalopathy: A Prospective Observational Study. Chin Med J (Engl) 129, 1674–1681 (2016). · DOI
  36. Heming, N. et al. Neuroanatomy of sepsis-associated encephalopathy. Crit Care 21, 65 (2017). · DOI · Paper page
  37. Kapural, M. et al. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res 940, 102–104 (2002). · DOI · Paper page
  38. Rosén, H., Sunnerhagen, K. S., Herlitz, J., Blomstrand, C. & Rosengren, L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 49, 183–191 (2001). · DOI
  39. Hasselblatt, M. et al. Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology 62, 1634–1636 (2004). · DOI
  40. Yende, S. et al. Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials. Crit Care Med 44, 1461–1467 (2016). · DOI · Paper page
  41. Hughes, C. G. et al. Relationships between markers of neurologic and endothelial injury during critical illness and long-term cognitive impairment and disability. Intensive Care Med 44, 345–355 (2018). · DOI

Cited by

See all 56

Metadata

Authors
Wu, L., Feng, Q., Ai, M.-L., Deng, S.-Y., Liu, Z.-Y., Huang, L., Ai, Y.-H., & Zhang, L.
Venue
Scientific Reports
Published
2020-05-07
Volume
10
Issue
1
Pages
7718-7718
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3022376850
Cited by
56
References
6
FWCI
5.22
Type
journal article
Language
en
Open access
gold
Licence
Funders
National Natural Science Foundation of China (81401099)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy. https://app.cochat.ai/papers/10.1038/s41598-020-64200-3
The paper
Wu, L., Feng, Q., Ai, M.-L., Deng, S.-Y., Liu, Z.-Y., Huang, L., Ai, Y.-H., & Zhang, L. (2020). The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy. Scientific Reports. https://doi.org/10.1038/s41598-020-64200-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.